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Fibril polymorphism affects immobilized
non-amyloid ﬂanking domains of huntingtin
exon1 rather than its polyglutamine core
Hsiang-Kai Lin1, Jennifer C. Boatz1, Inge E. Krabbendam2, Ravindra Kodali1, Zhipeng Hou3,w, Ronald Wetzel1,
Amalia M. Dolga2, Michelle A. Poirier3 & Patrick C.A. van der Wel1
Polyglutamine expansion in the huntingtin protein is the primary genetic cause of
Huntington’s disease (HD). Fragments coinciding with mutant huntingtin exon1 aggregate
in vivo and induce HD-like pathology in mouse models. The resulting aggregates can have
different structures that affect their biochemical behaviour and cytotoxic activity. Here we
report our studies of the structure and functional characteristics of multiple mutant htt exon1
ﬁbrils by complementary techniques, including infrared and solid-state NMR spectroscopies.
Magic-angle-spinning NMR reveals that ﬁbrillar exon1 has a partly mobile a-helix in its
aggregation-accelerating N terminus, and semi-rigid polyproline II helices in the proline-rich
ﬂanking domain (PRD). The polyglutamine-proximal portions of these domains are
immobilized and clustered, limiting access to aggregation-modulating antibodies. The
polymorphic ﬁbrils differ in their ﬂanking domains rather than the polyglutamine amyloid
structure. They are effective at seeding polyglutamine aggregation and exhibit cytotoxic
effects when applied to neuronal cells.
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H
untington’s Disease (HD) is the most prevalent example
of a family of neurodegenerative diseases that have the
abnormal expansion of a polyglutamine stretch (polyQ)
as their primary genetic cause1. HD is a devastating and as-yet
incurable disease in which the polyQ expansion occurs within the
ﬁrst exon of the huntingtin protein (htt exon1). As a result of
protease activity or missplicing, N-terminal fragments of the
mutant protein are generated, including the htt exon1 segment.
Misfolding, self-assembly and aggregation of these fragments
lead to a gain of toxic function, which ultimately leads to
neuronal death. The exact mechanism of toxicity remains
uncertain, and different studies report diverging levels of
toxicity (or lack thereof) for detectable htt exon1 aggregates,
with some reporting an apparent lack of correlation between
aggregate burden and toxicity2. However, it is increasingly
recognized that cells contain different types of aggregates,
including also ﬁbrillar aggregates that are not as easily detected
as large inclusions3–5. Such polymorphism is reminiscent of other
amyloids6,7, and is important, given that the toxicity of htt exon1
aggregates is known to depend on their structure8,9. Accordingly,
toxicity-reducing mechanisms in vivo may induce the generation
of aggregate species with reduced toxicity9–11, in parallel to
protein homeostasis and clearance mechanisms that reduce
aggregation.
The structural differences that underlie the polymorphism of
htt exon1 aggregates remain uncertain. Prior studies have
generally attributed them to the expanded polyQ domain, even
in cases where low-resolution structural data may not unambigu-
ously distinguish the polyQ and non-polyQ domains8,12.
While the expanded polyQ domain forms the ‘core’ of the
ﬁbrillar aggregates13–17, it has become clear that non-polyQ
‘ﬂanking’ domains (Fig. 1) have dramatic inﬂuences on the
misfolding and aggregation pathways of htt exon1 and other
polyQ proteins18–23. The highly conserved 17-residue N-terminal
ﬂanking segment (httNT) is important for the native function of
htt, but also initiates and accelerates aggregation of mutant htt
exon1 (refs 18–21). On the other hand, the C-terminal proline-
rich domain (PRD) reduces the innate aggregation propensity of
the preceding polyQ domain by modulating its conformational
ensemble24. These ﬂanking domains also are targets for
aggregation-modulating post-translational modiﬁcations
(PTMs), chaperones and antibodies (Fig. 1a)25–32. However, not
all exon1-binding proteins are effective at modulating
aggregation. While MW7 and other PRD-binding proteins
inhibit aggregate formation and cellular toxicity28–30,33,34, the
PRD-binding MW8 antibody does not30,35.
To understand exon1 aggregate polymorphism, the exon1
aggregation mechanism, and how both can be modulated by htt
exon1-binding proteins and PTMs, it is crucial to know the
structure of the aggregated species. We have been using magic-
angle-spinning (MAS) solid-state NMR (ssNMR) to study mutant
htt exon1 and shorter htt-derived peptide ﬁbrils13,15,17,32. MAS
ssNMR is a powerful tool for elucidating the structure of amyloid
ﬁbrils, and is the gold standard for identifying differences among
polymorphic amyloid structures7,36. Mutant htt exon1 ﬁbrils
feature a well-deﬁned amyloid core, consisting of polyQ
b-hairpins17, while the ﬂanking domains lack b-structure14–17.
In ﬁbrils formed by synthetic htt N-terminal fragments (HNTFs)
that behave similar to full-length exon1 (ref. 37), the httNT
segment features a short amphipathic a-helix13,15,32. Here we
refer to these httNTQ30P10K2 peptides (Fig. 1b) as HNTFs. A
recent ssNMR study on ﬁbrils prepared using thioredoxin-fused
htt exon1 failed to detect the signals for an a-helical httNT, raising
the possibility that httNT has a different structure in ﬁbrillar
exon1 (ref. 16). This is an important issue, as the presence of
a-helical httNT provided support for the idea that a-helical httNT
segments play a critical role in exon1 oligomerization and
aggregation13,15,20,21,32. Thus, prior studies of htt exon1 ﬁbrils
have been unable to offer a consistent picture of either the
detailed structure of the ﬁbrils (and in particular the ﬂanking
domains) or the origins of reported ﬁbril polymorphism. Here we
report MAS ssNMR studies of different ﬁbrils prepared from htt
exon1 featuring a disease-relevant 44-residue polyQ domain. We
ﬁnd that the httNT also in exon1 ﬁbrils contains a partly
immobilized a-helix, and probe in detail the structure and
dynamics of the C-terminal ﬂanking domain. The polyQ-
proximal region of the PRD is immobilized near the amyloid
core surface, reducing access to PRD-binding antibodies. An
obvious and reproducible temperature-dependent amyloid-like
ﬁbril polymorphism affecting the cytotoxic aggregates is reﬂected
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Figure 1 | Htt exon1 sequence and domain structure. (a) The domain structure and sequence of htt exon1 is shown at the top. The locations of PTMs,
as well as the binding sites of various antibodies and other htt-binding proteins are indicated25–34,58. (b) Design of previously studied13 HNTF peptide
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in detectable changes, not in the polyQ as previously suggested,
but rather in the non-amyloid ﬂanking domains.
Results
Fibril formation by disease-relevant mutant htt exon1. For
in vitro studies, mutant htt exon1 is usually expressed as a fusion
protein in which the N terminus of exon1 is fused to a soluble
protein tag to inhibit aggregation38–40. Cleavage of the linker
releases exon1, but commonly leaves behind a non-native
N terminus30,38–40. Such modiﬁcations of httNT can modify the
aggregation and toxicity of htt exon1 (refs 8,18), similar to the
effects of httNT mutations and PTMs20,32. We therefore generated
a fusion construct for htt exon1 with a 44-residue polyQ domain
that produces an N terminus just as it is encoded in the genome
when the fusion partner is cleaved15. A 10-residue linker segment
was eliminated from a previously used maltose-binding protein
(MBP) fusion protein construct40 to yield a new Factor Xa
cleavage site (IEGR-MATL) designed to generate the desired
17-residue httNT (Fig. 1c). To test for correct cleavage, we
performed SDS–PAGE and mass spectrometry analyses. Efﬁcient
protease cleavage is observed (Fig. 2a), resulting in release of
MBP and htt exon1 with the expected molecular masses
(Supplementary Table 1 and Supplementary Fig. 1). Thus, even
without the extended linker the cleavage site is easily protease-
accessible.
Using transmission electron microscopy (TEM) we observed
the aggregation of the released htt exon1 (ref. 17). Across a series
of independent aggregation trials we observed mature aggregates
that appear as elongated unbranched amyloid-like ﬁbrils, but
differed speciﬁcally in the ﬁbre widths. Consistent with prior
work8, we ﬁnd that the temperature at which the aggregation
occurs plays a critical role in dictating the ﬁbril morphology. At
37 C, narrow ﬁbrils are formed (Fig. 2b and Supplementary
Fig. 2a,b). Aggregation at 22 C yields larger ﬁbril widths (Fig. 2c
and Supplementary Fig. 2c,d). By Fourier transform infrared
spectroscopy (FTIR) both ﬁbril types (Fig. 2d,e) share the same
dominant features previously reported for other polyQ, HNTF
and htt exon1 ﬁbrils (for example, Fig. 2f)8,13,37,41,42. The two
ﬁbril species display a few differences in their less prominent
signals (arrows in Fig. 2e). The partly overlapping resonance
frequencies expected for a-helices, b-sheet polyQ amyloid
and PPII-helical oligoproline (oligoPro) are indicated in Fig. 2g
(refs 13,37,41–44). The differentiating FTIR signals show most
similarity to signals expected for the PRD, but an unambiguous
assignment is challenging. These polymorphic TEM and FTIR
features are reproduced in independently prepared samples
(for example, Supplementary Fig. 3).
SSNMR shows no evidence of polymorphism in the amyloid core.
To analyse the ﬁbril structure in more detail, we applied MAS
ssNMR to uniformly 13C and 15N (U-13C,15N)-labelled htt exon1
ﬁbrils (see Methods and Supplementary Table 2 for experimental
details). To identify the rigid domains we use experiments reliant
on cross-polarization (CP) and other dipolar-coupling-based
transfers, which ﬁlter out highly mobile residues. Figure 3a–c
compares the 1D 13C CP spectra of htt exon1 ﬁbrils prepared at
22 and 37 C. The spectra are essentially indistinguishable, with
no indication of substantial structural differences in the immobile
parts of the ﬁbrils. We gain more insights into these rigid
domains using two-dimensional (2D) spectra that afford site-
speciﬁc resolution and thus assignment of residues or residue
types (see Supplementary Table 3). Figure 4 shows a 2D 13C–13C
spectrum obtained with CP and dipolar-assisted rotational reso-
nance recoupling (CP/DARR). This spectrum is dominated by
signals from the polyQ amyloid core (boxed), with its highly
characteristic resonance frequencies13,15–17,45,46. A detailed
analysis of 2D spectra for the htt exon1 ﬁbrils prepared at
22 and 37 C (refs 15,17) reveals no detectable differences in
terms of the Gln chemical shifts, relative peak heights, cross-
correlation patterns or dynamics (see also below). This stands in
contrast to polymorphic Ab and a-synuclein ﬁbrils that are easily
distinguished by their ssNMR spectral differences indicative of
distinct amyloid core structures7,36, as well as prior reports of
signiﬁcant structural changes affecting the polyQ core itself 8,12.
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Figure 2 | Cleavage and aggregation of mutant htt exon1. (a) SDS–PAGE gels showing time-dependent factor Xa cleavage at 22 C. (b,c) Fibril width
derived from negative-stain TEM on the mature ﬁbrils formed at 37 C (597 measurements over 99 ﬁbrils) and 22 C (219 measurements over 73 ﬁbrils).
(d) Second-derivative FTIR of htt exon1 ﬁbrils formed at 37 C and (e) 22 C, for ﬁbrils dispersed in either H2O or D2O. The coloured arrows mark the most
notable differences between the ﬁbril types. (f) Reference data on ﬁbrillar K2Q31K2, HNTF (htt
NTQ30P10K2) ﬁbrils, and aggregated a-helical httNT in
PBS buffer, adapted with permission from ref. 13, Copyright 2011 American Chemical Society. (g) Resonance frequencies of different secondary structure
elements.
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Flanking domains feature immobilized a- and PPII helices.
The 2D CP/DARR spectrum also includes peaks (underlined
labels in Fig. 4a) that reproduce the a-helical httNT signals seen
previously in the HNTF ﬁbrils (Fig. 4b)13,15. The observed
resonance frequencies identify a localized a-helix, based on the
dependence of Ca and Cb chemical shift d on the backbone
structure. In Fig. 4c,d, this is visualized as positive
‘secondary shifts,’ Dd(Ca-Cb), for the a-helix spanning residues
4–11 of httNT (blue bars). The one-dimensional (1D) and 2D CP
spectra also feature peaks from the PRD. The dominant PRD
signals in Fig. 4a are for Pro residues with chemical shifts
characteristic of PPII helices, as previously seen in HNTF and htt
exon1 ﬁbrils15,16. A weaker, but still strong, second set of Pro
signals is observed with chemical shifts resembling those of Pro in
intrinsically disordered proteins (IDPs), indicating a random-
coil-like (ProRC) structure47. 13C direct-excitation spectra indicate
an B2:1 ratio of the two populations of Pro residues,
independent of the ﬁbril formation temperature (Fig. 3d–f and
Supplementary Fig. 4). Other, non-Pro, PRD signals are visible,
including peaks for the unique Gly and Val residues G100 and
V103. The fact that these httNT and PRD residues are visible in
CP-based spectra implies that both ﬂanking domains are partly
immobilized by interactions with the amyloid core or with each
other.
Restricted motion of the polyQ-proximal ﬂanking segments.
CP-visible residues may be immobilized, but can nonetheless
feature signiﬁcant and detectable dynamics15. Evidence of such
dynamics was obtained in a series of 13C–13C recoupling
experiments with proton-driven spin diffusion (PDSD) times of
0–500ms (Supplementary Fig. 5a–f). The transfer or buildup of
polarization (or signal) in such experiments is dependent on
dipolar couplings between nearby 13C and 1H atoms. Dynamics
cause an apparent reduction in these couplings, leading to slower
and weaker polarization transfer proﬁles as illustrated in Fig. 5a.
In a rigid crystalline peptide, directly bonded Ca–Cb carbons
show a fast polarization buildup that reaches a 10–20%
polarization transfer within the ﬁrst 10–20ms (solid lines).
Some variations in the polarization transfer are typical of the
complex mechanism underlying PDSD recoupling48.
Intermediate timescale molecular motion reduces the effective
dipolar couplings and increases relaxation, causing a reduction in
both the transfer rate and the transfer maximum15. Fully dynamic
molecules, such as those in solution, experience complete
averaging of the dipolar couplings and, therefore, a lack of
13C–13C transfer (dashed line). Thus, these PDSD buildup
proﬁles can be used to detect dynamics.
In the exon1 ﬁbrils, we observe a fast buildup and high
maximum for Ca–Cb peaks of the amyloid core Gln (Fig. 5b) that
indicates a crystal-like rigid structure. Small variations among the
curves are most likely explained by the complex PDSD
mechanism rather than changes in dynamics. Much larger
changes are seen in Fig. 5c, which shows the buildup curves for
the ﬂanking domain Ala signals. Compared to the Gln, the
buildup is slower and the attained maximum is much reduced.
These dramatic differences in the PDSD buildup curves can only
be explained by motion-induced reductions of the dipolar
couplings and increases in relaxation. In the PRD, we see that
both types of Pro (PPII and random coil) have one-bond signal
transfer (Fig. 4d) that is both lower and slower than that of the
amyloid core (Fig. 4b). Two-bond Ca–Cg transfers reveal a
difference between IDP-like and PPII Pro (Supplementary
Fig. 5g), which indicates that the former undergo increased
dynamics. As a secondary probe of these dynamics, we also
measured the motional averaging of 1H–13Ca dipolar couplings
for the Pro and Gln residues, using a dipolar-chemical shift
(DIPSHIFT) experiment15,49. The results of these experiments
match the results of the PDSD-based measurements. Unlike the
dipolar oscillations of the rigid Gln backbones, the Pro residues
experience attenuated 1H–13C dipolar couplings (Supplementary
Fig. 6). The PRDs of ﬁbrils formed at 22 C appear to be slightly
more dynamic compared to the 37 C ﬁbrils. Thus, Pro residues
in the ﬂanking domains in htt exon1 ﬁbrils have an intermediate
timescale dynamic behaviour similar to those of the httNT
a-helices15.
Variable dynamics of the PRD ﬂanking domains. CP-based
ssNMR spectra of the polymorphic ﬁbrils showed no chemical
shift differences in the polyQ amyloid core or immobilized parts
of the ﬂanking domains; however, there is evidence of motional
differences in the latter. To test for differences in more dynamic
parts of the ﬁbrils, we turn to a different set of motion-sensitive
ssNMR experiments. Solution-NMR-like INEPT (Insensitive
Nuclei Enhanced by Polarization Transfer) spectra require nuclei
to experience slow 1H T2 relaxation in absence of 1H–1H
decoupling, and thus show only residues with very high mobility.
Both the 22 and 37 C ﬁbrils yield peaks in INEPT spectra
(Fig. 3g–i). Strikingly, we observe a lot more signal for ﬁbrils
formed at 37 C compared to those obtained at 22 C. Both exon1
samples differ from httNTQ30P10K2 ﬁbrils, which show no INEPT
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signals, suggesting that the dynamic residues are in the latter part
of the PRD that is missing from such peptides13,15,16. In 2D
13C–13C INEPT/TOtal through Bond correlation Spectroscopy
(TOBSY) spectra for both ﬁbril types (Fig. 6) peaks are observed
that differ from those in the 2D CP-based spectra (see overlay in
Supplementary Fig. 7), with a few exceptions discussed below. On
the basis of the 2D data, we can assign the mobile residues or
residue types, as marked in Figs 3 and 6. The strongest peaks are
from Pro residues (for example, Fig. 3i), with other peaks
reﬂecting residue types that are only present in the tail end of the
PRD: Val103, E105, E106 and Arg110. The chemical shifts
indicate that this highly mobile C-terminal tail is unstructured.
As noted, the efﬁciencies of CP and INEPT-based spectra have
opposite dependencies on molecular motion. Mobile residues
visible as strong peaks in INEPT spectra are expected to be
missing from CP-based spectra. A residue with a prominent CP
signal, in contrast, must be in some way immobilized, have fast T2
relaxation and thus be invisible in INEPT spectra. Seeing
substantial peaks from the same residue in both spectra
(Supplementary Fig. 7) implies that such a residue is present in
different subpopulations that have markedly different mobilities.
Intriguingly, this applies to many of the PRD signals: the PPII
Pro, the IDP-like Pro, as well as V103. Overall, B2/3 of the Pro
are in PPII structure (Supplementary Fig. 4a,b). However, among
the INEPT-visible mobile prolines it is the IDP-like peaks that are
dominant (Supplementary Fig. 4c). We conclude that different
molecules throughout the sample have PRDs with different
degrees of ﬂexibility. When comparing the ﬁbril polymorphs, in
the 37 C ﬁbrils the population of proteins with dynamic PRDs is
notably larger, even though the overall ratio of PPII to
unstructured Pro remains the same (Supplementary Fig. 4a,b).
Polymorphic differences in PRD motion and accessibility. As
protein dynamics often correlate to solvent interactions, we
submitted both ﬁbril forms to ssNMR measurements that can
evaluate solvent exposure in a residue-speciﬁc manner. The
employed experiments ﬁrst eliminate the 1H–13C CP signals
generated from proteinaceous hydrogens by ﬁltering out the latter
based on their faster T2 relaxation. Then, we detect the signal
recovery as a function of time-dependent transfer of solvent
1H polarization into the ﬁbril. Residues that are most solvent-
exposed recover the fastest, while those that are buried take
longer to re-appear. Figure 7a,b compares the overall, unﬁltered
CP signal (grey line) to the partly repolarized ﬁbril signal after
7ms of 1H–1H diffusion (blue), with both spectra normalized to
their maximum peaks. In the 37 C ﬁbrils the highest signal
recovery is seen for Pro residues, indicating a high degree of
solvent accessibility for the PRDs. The repolarization is fastest for
the IDP-like Pro, consistent with their higher mobility. The data
for the 22 C ﬁbrils are different, in that the polarization transfer
to the PPII Pro trails that of other parts of the ﬁbrils. Thus, in
these samples the PPII helices have a surprisingly reduced solvent
accessibility, consistent with their more restricted motion.
Conversely, the signals from httNT are notably enhanced
(upon 7ms 1H–1H transfer) compared to the 37 C ﬁbrils,
reminiscent of the httNT a-helix in HNTF ﬁbrils13,15. Thus, the
ﬂanking domains in these polymorphic ﬁbrils feature correlated
differences in their dynamics and solvent exposure.
Occlusion of the PRD domains limits antibody access. Next, we
examined a number of biochemical or functional characteristics
of the htt exon1 ﬁbril polymorphs. First, dot blot experiments
were used to probe the domain-speciﬁc accessibility of the
ﬁbrils to htt-exon1-speciﬁc antibodies35 (Fig. 7c). In line with
prior reports30,35, exon1 ﬁbril formation causes region-speciﬁc
reductions in the binding of antibodies to their epitopes. PolyQ-
binding MW1 antibodies bind monomers, but have very low
afﬁnity for ﬁbrils (Fig. 7c), because of complete sequestration of
their epitopes30. The epitopes of the MW7 and MW8 antibodies
are in the oligoPro segments and C-terminal PRD tail,
respectively (Fig. 1a)35. MW8 binds to the PRDs of our mature
exon1 ﬁbrils, with an efﬁciency that is similar to the unaggregated
protein (Fig. 7c). MW7 shows a reduced afﬁnity to the aggregates,
with the largest reduction in binding seen for the wider 22 C
ﬁbrils, which suggests an increased sequestration of its epitopes in
those aggregates. These ﬁndings are consistent with prior studies
that probed aggregated mutant htt exon1 with these antibodies,
both in vitro and as cellular inclusions30,35.
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permission from ref. 13, Copyright 2011 American Chemical Society.
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Seeding activity and cytotoxic effects of the polymorphs. We
also compared the seeding activity of two polymorphs using a
previously reported seeding assay50. Figure 8 shows the results of
this assay in which aggregation at 22 C in presence and absence
of 20mol-% of pre-aggregated seeds was monitored by thioﬂavin
T (ThT) ﬂuorescence and HPLC-based monomer concentration
measurements. In absence of seeds, aggregation (after trypsin
cleavage) initiates with a lag phase that exceeds 4 h (Fig. 8b,d).
The presence of seeds abolishes the lag, leading to a signiﬁcant
decrease in the half time of aggregation. This seeding ability
affects expanded polyQ proteins (Fig. 8) and shorter peptides
with a 23-residue polyQ domain (Supplementary Fig. 8).
To probe for potential cytotoxic effects, we exposed two
neuronal cell types to micromolar concentrations of each
polymorph. Two different neuronal cell types were tested: an
immortalized murine hippocampal neuronal cell line and human
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differentiated dopaminergic neurons51–53. Fibrils were applied at
different concentrations (0.5, 1 and 5 mM). The low concentration
of 0.5 mM did not induce any cell death in either of the neuronal
cell types, while we detected differential neuronal toxicity with
1 mM that induced dopaminergic cell death but not in
immortalized neuronal cells. At higher concentrations, ﬁbrils
promoted neuronal cell death in both cell types. Our results
suggest that human dopaminergic neurons are more susceptible
to this external stimulus since neuronal death occurred at lower
ﬁbril concentrations (Fig. 8e,f). Across independently performed
assays, some variability was observed, but most of the data
indicate a slightly larger impact from the thinner ﬁbrils formed at
37 C. One indicator of this difference is also seen in the treated
neurons’ morphology, which is noticeably changed by the
ﬁbrils formed at 37 C, but not by those prepared at 22 C
(Supplementary Fig. 9). Thus, both ﬁbril polymorphs are
biologically active, with the in vitro seeding assays and
cytotoxicity measurements indicating a modest, but nonetheless
detectable, difference between the two polymorphs.
Discussion
We prepared amyloid-like ﬁbrils from mutant htt exon1 that
lacked undesirable modiﬁcations of its crucial httNT segment, and
studied the ﬁbril structure and how it depends on the ﬁbrillation
temperature. At 22 and 37 C we obtained amyloid-like ﬁbrils with
different widths (Fig. 2), of 15 and B6 nm, respectively. When
examined by FTIR, speciﬁc differences were apparent in smaller
signals present alongside the invariant dominant polyQ core
signals (Fig. 2d,e). The ﬁbrils’ highly rigid polyQ domains also
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intensities after 7ms 1H–1H diffusion from the solvent into the ﬁbrils (blue)
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featured the same characteristic ssNMR signature46. In prior
work on these same htt exon1 ﬁbrils15,17, we used ssNMR to reveal
B20-residue-long b-strands forming a b-hairpin structure within
the aggregated polyQ domain and used in silico analysis to show
that alternative polyQ models have distinct ssNMR spectral
signatures.
By CP-based ssNMR we observed signals from the httNT
a-helix previously observed in HNTF peptide ﬁbrils13,15,32,
showing its presence in full-length mutant htt exon1 ﬁbrils. The
exon1 httNT helix experiences signiﬁcant dynamics that reﬂect
molten-globule-like dynamics also seen for a-helical httNT in
HNTF ﬁbrils15. These dynamics reduce ssNMR peak intensities
and may in part explain why previously published ssNMR spectra
of mutant htt exon1 ﬁbrils failed to show signal from the httNT
(refs 15,16). It is also possible that the exon1 aggregation process
was modulated by residual httNT-attached linker residues16,
which are avoided in our exon1 and HNTF constructs with
unmodiﬁed 17-residue httNT segments. Our observation of
a-helical structure in the httNT of ﬁbrillar exon1 lends further
support to the idea that a-helical httNT interactions play key roles
in the htt exon1 aggregation mechanism. HttNT is thought to
initiate and accelerate aggregation via the formation of httNT-
httNT a-helical bundles13,25,41. Flanking domain interactions play
similarly important roles in the aggregation pathways of other
polyQ disease proteins22,23.
The most notable ssNMR signals for the PRD are from
prolines, present in both PPII and IDP-like random-coil
structures. Their relative populations, estimated from direct-
excitation 13C spectra, appear to be 2:1 independent of the ﬁbril
formation temperature (Supplementary Fig. 4a,b). The PPII
structure is likely due to the two oligoPro segments of the PRD
(Fig. 1a), of which ssNMR previously showed the ﬁrst to adopt a
PPII structure in HNTF ﬁbrils13,15. The 2:1 intensity ratio shows
that the remaining 10 Pro of the PRD do not form stable PPII
helices. Perhaps surprisingly, this is not accompanied with IDP-
like dynamics, given that the IDP-like Pro are visible in CP
spectra. The PDSD and DIPSHIFT experiments indicate similar
dynamics for both types of CP-detected Pro residues (Fig. 4).
Interestingly, signiﬁcant CP-based signals are seen for residues up
to V103. Thus, these parts of the PRD that do not occupy regular
secondary structure are, nonetheless, not free to move around.
We attribute this lack of motion to intermolecular interactions
due to clustering of PPII- and a-helical ﬂanking domains23,54.
Such interactions also explain the reduced binding by the MW7
antibody (Fig. 7c), while the C-terminal tail is ﬂexible and
accessible for strong MW8 binding (Fig. 7c). Thus, are data reveal
a transition from a polyQ-proximal semi-rigid PRD segment to a
highly dynamic ﬂexible tail, with an apparent transition point at
or near residue V103. This is sketched schematically in Fig. 9a,
with the mobile C-terminal tail segments shown top right in red.
The immobilized PRD segments are not as rigid as the b-sheet
polyQ amyloid core, as they experience dynamics similar to those
of the httNT a-helices15.
The INEPT-based ssNMR spectra also contain signals from
both IDP-like and PPII-helical Pro, indicating the presence of
exposed and highly dynamic PPII helices in a subset of the
protein molecules in the sample. The HNTF ﬁbrils without
C-terminal PRD segments lack such INEPT signals. We speculate
that the ﬁrst oligoPro segment is typically immobilized in
its location directly attached to the immobile polyQ core
(see ref. 15), while the mobile segments are in the latter part of
the PRD (top right of Fig. 9a). Those exon1 monomers with the
more mobile PRDs should be more accessible to interacting
proteins, including the MW7 antibody (Fig. 7c).
Prior studies have indicated polymorphism in aggregates
formed by htt exon1 and other N-terminal fragments, with
corresponding effects on the aggregates’ cellular toxicity4,8,9,12.
Both in our hands (Fig. 2) and in earlier work8, FTIR indicated
structural differences between exon1 ﬁbrils made at different
temperatures. By ssNMR we observe differences not in the polyQ
domain, but rather in the other exon1 domains. For instance, the
PRD domains of 37 C ﬁbrils have a larger proportion of highly
ﬂexible (Fig. 3i) and solvent-exposed (Fig. 7) residues. Conversely,
Pro residues in 22 C ﬁbrils are more restricted in their motion
(Fig. 3) and less solvent-accessible (Fig. 7). Thus, unlike prior
studies8,12, we ﬁnd the polymorphism to be predominantly
reﬂected in the dynamics and accessibility of the non-amyloid
ﬂanking domains.
As discussed previously15, ﬁbrillar httNT a-helices are
stabilized by intermolecular interactions that immobilize them
enough to render them visible by CP ssNMR. These httNT
interactions are important for the oligomerization of htt exon1
and contribute to the stability of the ﬁbrils32. We propose that in
the mature ﬁbrils ﬂanking domain interactions similarly sequester
and immobilize the PRD domains, and thus limit accessibility and
binding by proteins for the most Pro-rich parts of the PRD—for
example, the MW7 antibodies (Fig. 7c). The origins of this are
found in the polyQ amyloid core. SSNMR studies of aggregates
formed by polyQ-expanded exon1 and polyQ peptides note that
polyQ amyloid contains long antiparallel b-strands with few turn
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Figure 9 | Schematic proposed model of htt exon1 ﬁbrils. (a) The httNT a-helices (dark blue) and PRD PPII helices (light blue) are immobilized and tightly
clustered on the perimeter of the rigid amyloid core (green b-strands). C-terminal domains show increased dynamics, either in the form of the unstructured
C-terminal tail or a subpopulation of more exposed PRDs (top right; red). An individual protein monomer with its b-hairpin-based polyQ core is shown with
lighter (yellow) b-strands. (b) Schematic illustration of interﬁlament ﬂanking domain interactions that we propose to explain the larger TEM-based widths
of the ﬁbrils formed at 22 C, as well as the observed differences in accessibility and immobilization of the PRD.
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regions17,45. In our mutant htt exon1 ﬁbrils with 44-residue
polyQ domains, we observe 90% of the residues in the b-sheet
parts of b-hairpins, separate from the B10% of polyQ residues
that form the single intervening b-turn17. The intramolecular
b-hairpin places ﬂanking domains in close proximity to each
other in the assembled ﬁbril, limiting their freedom of motion
and accessibility (Fig. 9). The polyQ-proximal secondary
structure elements are further constrained by the short linkers
that connect them to the rigid amyloid core13,15. Thus, the b-
sheet ﬁbre core is surrounded by sterically constrained and
densely packed a- and PPII-helical ﬂanking domains, in contrast
to reports that the PRD is primarily dynamic14,16. Figure 9a
shows a schematic structural model designed to illustrate the
relative dimensions of the ﬂanking domains and an amyloid core
featuring 20-residue b-strands. The latter part of the PRD is likely
only weakly immobilized in a single, B6 nm-wide, ﬁlament. We
hypothesize that the structural and motional features of the
B15 nm-wide 22 C ﬁbrils are most easily explained by ﬂanking
domain interactions tying together two ﬁlaments, as illustrated in
Fig. 9b. This would intertwine the polyQ-proximal ﬂanking
segments of the ﬁlaments through additional interactions among
the a- and PPII helices54. Nonetheless, as detected in PDSD and
DIPSHIFT experiments, these ﬂanking domains retain molten-
globule-like dynamics that greatly reduce the dipolar coupling
constants and thus limit ssNMR sensitivity and complicate long-
range distance measurements.
Both ﬁbril polymorphs have a strong seeding ability that affects
both expanded and non-expanded polyQ aggregation (Fig. 8 and
Supplementary Fig. 8). Intriguingly, a small, but seemingly
signiﬁcant, difference is observed between the two polymorphs.
This difference in seeding activity shows opposite trends for the
two different target peptides, which precludes a straightforward
explanation in absence of further studies. Both ﬁbril polymorphs
were also shown to have cytotoxic and morphological effects when
provided extracellularly to neuronal cells, with a more visible
impact by ﬁbrils formed at 37 C. On the basis of the available data,
it remains unclear what dictates the differences in seeding ability
and toxicity, and whether or how these two activities may be
related. In terms of the cellular impacts, it is likely that a key
determinant relates to the ability of ﬁbrils to be taken up, which
may depend on the ﬁbril stability and width8,55,56. The exposure
of httNT and PRD domains may also be signiﬁcant as they
modulate interactions with cellular membranes, which may also
affect cellular uptake and cytotoxic membrane disruption57.
Thus, our results point to differences in the ﬂanking domains’
exposure and interactions as being important in htt exon1
aggregates’ structure and function. Factors that modulate ﬂanking
domain interactions are known to affect cellular toxicity. In httNT,
these factors include covalent PTMs and non-covalent binding by
chaperones and antibodies25,32,58. The intimate interactions of
the polyQ-proximal PRD segments in the ﬁbrils rationalize the
ﬁnding that also PRD-binding proteins interfere with exon1
aggregation, unless they bind the disordered tail28–30,33,34. Such
PRD-based aggregation-inhibiting effects are harder to reconcile
with a ﬁbril model in which the entire PRD is ﬂexible and
exposed14,16. An intriguing question is how ﬂanking domain
arrangements may affect cellular toxicity, resistance to clearance
mechanisms, membrane interactions or ﬁbrils’ ability to sequester
other proteins59,60. Further structural studies will be critical to
gain a complete understanding of exactly how htt exon1 aggregate
structure, stability and toxicity are correlated.
Methods
Protein expression and puriﬁcation. The plasmid encoding mutant htt exon1
with 44 consecutive glutamine residues was modiﬁed from a MBP-fusion construct
described previously40. A single-step deletion mutagenesis reaction using the
QuikChange II XL site-directed mutagenesis kit (Agilent Technologies, Santa Clara,
CA, USA) was used to remove from the MBP–exon1 linker region 10 amino acids
(ISEFGSMSTGGG), which would otherwise remain attached to the exon1 N
terminus following Factor Xa cleavage. The employed primer sequences were 50-
CAACCTCGGGATCGAGGGAAGGATGGCGACCCTGGAAAAGCTTATG-30
and 50-CATAAGCTTTTCCAGGGTCGCCATCCTTCCCTCGATCCCGAGG-
TTG-30 . The htt exon1 construct was codon-optimized by GenScript (Piscataway,
NJ), using the OptimumGene algorithm for expression in Escherichia coli (yielding
50-AGTAGCAACAATAATAATAATAACAACAACAACAACCTGGGTATC-
GAAGGCCGTATGGCAACGCTGGAAAAACTGATGAAAGCATTTGAATCC-
CTGAAAAGTTTCCAGCAGCAACAACAACAGCAACAGCAGCAGCAGCAG-
CAACAGCAGCAGCAACAACAGCAGCAACAACAGCAACAGCAACAACAA-
CAACAGCAGCAACAGCAACAACAACAGCAGCAGCAGCAACAGCAA-
CAGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCAACTGCCG-
CAACCGCCGCCGCAGGCGCAACCGCTGCTGCCGCAGCCGCAGCC-
GCCGCCGCCGCCGCCGCCGCCGCCGCCGGGCCCGGCTGTTGCTGAA-
GAACCGCTGCATCGCCCGAGTGGCTCCCATCACCATCACCATCAT-30).
This construct was subcloned into the pMALc2x plasmid through the restriction
digest sites EcoRI and HindIII.
The fusion protein was overexpressed in E. coli BL21(DE3)pLysS cells
(Invitrogen, Grand Island, NY). Isotopic labelling followed an optimized isotopic
labelling protocol61, starting by growing the cells in 1 l LB medium with ampicillin
and chloramphenicol at 37 C and 250 r.p.m. until an optical density (OD600) of
B0.65. The cells were pelleted at 1,677g for 15min, resuspended in 50ml M9 salt
solution lacking nitrogen and carbon sources and then pelleted again at 1,677g for
15min, prior to resuspension in 250ml M9 media containing U-13C-D-glucose and
15N-ammonium chloride (Cambridge Isotope Laboratories, Tewksbury, MA). The
cells were brought to their fast growth phase by cultivating at 37 C for 30min and
250 r.p.m. A temperature ramp from 37 to 18 C over 30min at 250 r.p.m. was
applied, followed by 30min at 18 C, to prepare for induction. Protein expression
was induced by adding 0.8mM isopropyl b-D-thiogalactopyranoside (RPI Corp.,
Mt Prospect, IL), along with 0.02% (w/v) [13C]-D-glucose, 0.01% (w/v) [15N]
ammonium chloride and 100 mM ZnSO4. The fusion protein was overexpressed at
18 C for 16 h, after which the cells were pelleted for 20min at 7,000g. Cell pellets
were stored at  20 C at least 12 h before lysis. To lyse the cell, cell pellets were
thawed on ice for 30min. Then, the pellets were resuspended in buffer A, which is
PBS (pH 7.4) containing 0.02% (w/w) sodium azide that had been sterilized by
ﬁltration through a Nalgene Rapid-Flow 500ml bottle top 0.2 mm ﬁlter (Thermo
Scientiﬁc, Waltham, MA). The resuspended cells were kept on ice, following
addition of 1mM phenylmethanesulfonyl ﬂuoride (ACROS, Fair Lawn, NJ), and
2mgml 1 lysozyme (Hampton Research, Aliso Viejo, CA). After 40min., cells
were broken by sonication (Misonix Inc., Farmingdale, NY) on ice, applying
B40W of sonication for a total of 20min, alternating 10 s pulses and breaks of
10 s. Cell debris was removed by centrifugation (38,720g for 1 h). The soluble fusion
protein was puriﬁed into PBS buffer over a 50–200mM imidazole gradient using a
nickel column, and then buffer-exchanged into PBS buffer to remove the residual
imidazole15. Purity and identity were veriﬁed by SDS–PAGE (12%) and
electrospray ionization time-of-ﬂight mass spectrometry (Genomics and
Proteomics Core Laboratories, University of Pittsburgh), which was also used to
verify the molecular mass and isotopic labelling (where applicable) of the fusion
protein, the cleaved MBP solubility tag and the htt exon1 monomer.
Fibril formation. The puriﬁed fusion protein was buffer-exchanged to buffer A
(deﬁned above) using centrifugal ﬁlter units (Millipore, Billerica, MA). To release
htt exon1, the fusion protein was cleaved by treating with Factor Xa (Promega,
Madison, WI) at 22 or 37 C, as indicated. After addition of 0.55 mg of Factor Xa to
a 10ml 44.7 mM solution of the fusion protein (28.7 mg), the progression of cleavage
and aggregation was monitored by SDS–PAGE (Bio-Rad Mini-Protein Precast
TGX Gels 12%) and TEM (see below). The full SDS–PAGE gels are also shown in
Supplementary Fig. 1. Samples (10.5 ml) were mixed with an equal volume of SDS–
PAGE loading dye to terminate the reaction, and then analysed by SDS–PAGE
(Bio-Rad Mini-Protein Precast TGX Gels 12%). For MAS ssNMR studies, uni-
formly 13C- and 15N-labelled (U-13C,15N) fusion protein was cleaved and allowed
to aggregate over 3 days, after which the labelled htt exon1 ﬁbrils were pelleted
down at 3,000g for 20min and resuspended in 1ml buffer A. MAS ssNMR samples
were packed in 3.2mm MAS ssNMR sample holders (Bruker Biospin, Billerica,
MA, and CortecNet, Brooklyn, NY) using a home-built ultracentrifugal sample-
packing tool62 operated for 1 h at 150,000g. The supernatant was discarded, and
pelleted ﬁbrils were washed at least three times with buffer A prior to sealing of the
MAS rotor.
Transmission electron microscopy. The ﬁbril morphology and progression of
ﬁbril formation by htt exon1 were monitored using negative-stain TEM. Aliquots
of sample were diluted with PBS buffer, and then deposited onto freshly glow-
discharged carbon-coated copper grids. After removal of excess buffer, grids were
treated with negative stain that was adsorbed for 30 s prior to blotting. The 22 and
37 C exon1 ﬁbrils were stained with 1% (w/v) uranyl acetate and 1% phospho-
tungstic acid, respectively. The 22 and 37 C exon1 ﬁbrils in Supplementary Fig. 3
were stained with 1% (w/v) uranyl acetate. Images were obtained at 6,500–30,000-
fold magniﬁcation using a Tecnai T12 TEM (FEI, Hillsboro, OR) operating at
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120 kV and equipped with an UltraScan 1000XP CCD camera (Gatan, Pleasanton,
CA). Fibril widths were measured using ImageJ’s straight line freehand tool
(NIH, Bethesda, MD). Each measurement spanned the length of the negative-
stained area of the ﬁbre with similar contrast. Pooled positive stain on the edges of
the ﬁbres was not included in the measurements. In images with low resolution, the
ﬁbre diameter was determined in regions with the clearest deﬁned boundaries.
At least three measurements were obtained per ﬁbre.
FTIR spectroscopy. FTIR spectroscopy was performed using an MB series spec-
trophotometer with the PROTA software (ABB Bomem, Quebec City, QC,
Canada). Aggregates were harvested by centrifugation for 30min at 20,817g in a
tabletop Eppendorf 5415C centrifuge, and pellets washed three times with PBS
buffer. Pellets containing aggregates were resuspended in either PBS buffer or
deuterated PBS buffer at around 10mgml 1 concentration and incubated for 24 h.
Spectra of the resuspended aggregates were acquired at room temperature by
placing the aggregate suspension between two polished CaF2 windows using a
BioCell module (BioTools Inc.). Data from a total of 400 scans were collected with
4 cm 1 resolution at room temperature. Spectra were corrected for residual buffer
absorption by subtracting the appropriate buffer-alone spectrum interactively until
a ﬂat baseline was obtained between 1,700 and 1,800 cm 1. Second-derivative
spectra for the amide I region were calculated from the primary spectrum by using
the PROTA software.
Dot blot antibody-binding assays. Identically sized aliquots of samples con-
taining 1 mg of unaggregated MBP-fusion protein or aggregated protein in buffer A
were transferred to a nitrocellulose membrane using a Bio-Dot apparatus (Bio-Rad,
#170–6,545). Blots were incubated overnight with Odyssey Blocking Buffer (PBS)
from LI-COR Biosciences (Lincoln, NE, USA), washed three times with TBST
(10mM Tris-HCl, pH 7.5, 150mM NaCl, 0.1% (v/v) Tween-20, 0.05% (w/v)
sodium azide) and incubated with a 1:5,000 dilution of the appropriate antibodies
for 3 h. Two independent dot blot assays were performed. The MW1, MW7 and
MW8 antibodies developed in the Patterson lab35 were obtained from the
Developmental Studies Hybridoma Bank (DSHB), created by the NICHD of the
NIH and maintained at The University of Iowa, Department of Biology, Iowa City,
IA. As controls, we obtained from the DSHB, 2A12 anti-GASP (deposited by
Krasnow, M.A.; DSHB Hybridoma Product 2A12) and anti-glass-bottom boat
(GBB 3D5-24; Guillermo Marque´z; University of Minnesota) antibodies against
drosophila proteins. After washing with TBST to remove unbound material, blots
were incubated for 2 h with a 1:10,000 dilution of Alexa Flour 680 conjugate of
anti-mouse IgG (Invitrogen, A21057) and then washed four times with TBST. Blots
were visualized using a LI-COR Odyssey Infrared Imaging System (LI-COR
Biotechnology, Lincoln).
Seeding assays. The aggregates’ seeding ability was measured using seeding
assays21,37,50. As seeding material, mutant htt exon1 ﬁbrils were obtained after
5 days of aggregation at 22 and 37 C, using starting monomer concentrations of
0.2mgml 1 (15.5 mM) and 0.14mgml 1 (10.1 mM), respectively. The aggregates
were pelleted at 3,220g for 10min, followed by four washing steps with PBS buffer.
The ﬁnal aggregates were resuspended and vortexed for 30min, and then sonicated
for 10 s followed by 10 s of rest time for a total of 30 s sonication time. The freshly
sonicated samples were incubated on ice for 5min and then used as seeds the
seeding experiments. Several complementary seeding assays were performed; the
ﬁrst involving a previously described htt exon1-seeding protocol50 that measures
the effects of the seeds on the aggregation kinetics of our fusion protein upon
trypsin cleavage. The protease cleavage was performed for 10min on ice at a
protease/substrate molar ratio of 1:3, after which the reaction was quenched with
phenylmethylsulfonyl ﬂuoride inhibitor/substrate molar ratio of 150:1. The
reaction mixture was split into three samples. To two of the samples 20mol-% of
pre-aggregated seeds were added. Next, the volume of all samples was adjusted with
PBS to obtain a polyQ monomer concentration of 11.6 mM, after which aggregation
was done at 22 C. For each sample the aggregation progression was monitored
using a combination of ThT assays (in duplicate or triplicate; see below) and a
complementary HPLC-based assay, which detect the aggregated and monomer
protein, respectively. These methods are described below. Complementary seeding
assays probed the effect of the 20mol-% of the exon1 ﬁbril seeds on the aggregation
at 37 C of httNTQ23P10K2 peptide. The httNTQ23P10K2 was prepared and
disaggregated21 in 1:1 (v/v) mixture of triﬂuoroacetic acid (TFA) and
hexaﬂuoroisopropanol overnight. The buffer was evaporated off under a N2 stream
and the peptide was dried under vacuum for 1 h. The residue was dissolved in H2O
adjusted to pH 3 with TFA. Residual aggregates were removed by
ultracentrifugation at 386,000g for 1 h, after which the pH was adjusted to 7.0 using
10 PBS buffer that was subsequently diluted 10-fold. Next, the seeds were added
and the reaction kinetics monitored (in presence and absence of seeds) using ThT
and HPLC-based assays, described below.
ThT ﬂuorescence assays. Aggregates were resuspended by aspiration and ali-
quots were diluted into a ThT stock solution (5 mM ThT, 10mM sodium phos-
phate, 150mM NaCl, pH 7.0). Samples were excited at 445 nm and the emission
was recorded at 489 nm over several seconds on a FluoroMax-4 spectroﬂuorometer
(Horiba; Kyoto, Japan). The excitation and emission slits were 2 and 4 nm,
respectively. The ThT assays on the seeded aggregation at 22 C starting with the
htt exon1 fusion protein were performed in duplicate, except for the following
measurements performed in triplicate: 22 C seeds: 15, 45, 75, 105, 195 and
735min.; 37 C seeds: 15, 45, 75 and 135min. The corresponding ThT measure-
ments of the unseeded aggregation were performed in duplicate, except for trial 1’s
ﬁrst four points (which were measured in triplicate) and its ﬁnal time point that
was measured once. The ThT assays of the seeded aggregation at 37 C of the
httNTQ23P10K2 peptide were based on duplicate measurements, except for triplicate
measurements of the 1,200, 1,740 and 2,700min time points (37 C seeds), and
single measurements at 60min (both seeds). The corresponding ThT assays of the
unseeded material were performed in duplicate, except for 2,700min time point
that was measured in triplicate and the 60min point that was measured once.
HPLC-based sedimentation assay. As a complementary assay to the ThT assays
of seeded and unseeded aggregation, we also performed a single measurement each
of the peptide monomer concentration using an established HPLC-based sedi-
mentation assay21,63. To do so, an aliquot was removed from the reaction mixtures
at the indicated time points, and the solid material was pelleted at 20,800g for
15min. The supernatant was diluted 2 in formic acid, and loaded on an Agilent
Zorbax SB-C8 4.6 50mm column (1.8 mm particle size) using an analytical HPLC
(Agilent Technologies). The monomer was eluted over a 15–35% gradient of
acetonitrile in water, with 0.05% TFA at 37 C. The elution of the monomer species
was monitored by absorbance at 215 nm (A215), as it has no signiﬁcant absorbance
at A280. The relative amount of monomer in each sample was determined by
integration of A215 peaks using the manual integration analysis mode with a
manually deﬁned linear baseline correction as provided by the ChemStation for the
LC systems software (Agilent Technologies). To estimate the error in this manual
integration and baseline correction, three independent integrations were applied to
each datapoint, yielding an approximate measurement error of 5% in most of the
measured values (see individual error bars in Fig. 8).
Neuronal toxicity assays. Htt exon1 aggregates were prepared at 22 and 37 C, as
described above, at concentrations of 14.5 and 10.1 mM, respectively. The resulting
ﬁbrils were examined by negative stain TEM to verify the generation of the wide
and narrow ﬁbril polymorphs. After 1 week, the aggregated material was resus-
pended by aspiration followed by vortexing and shaking for 30min. The remaining
material was pelleted at 3,220g for 10min, and the soluble MBP was removed by
buffer exchange three times into PBS (0.02% w/v NaN3). After the samples were
thoroughly resuspended, they were sonicated as described above. Before use in the
toxicity assays, the ﬁbrils were washed three times with PBS buffer and sonicated.
The employed LUHMES cells are human-differentiated neurons derived from a
clone of MESC2.10 cells. These human dopaminergic neurons were extensively
studied and validated previously51–53,64. The employed cells were kindly provided
to us by Professor Marcel Leist (University of Konstanz, Germany), and were used
without further authentication. The cells were tested for mycoplasma
contamination and were found to be mycoplasma-free. Non-differentiated
LUHMES cells were grown in coated plates with poly-L-lysine (0.1mgml 1) in
growth medium (DMEM/F12 medium supplemented with 1% N2-supplement
(Life Technologies, Carlsbad, CA, USA), 100Uml 1 penicillin, 100mgml 1
streptomycin and 0.04 mgml 1 basic ﬁbroblast growth factor (R&D Systems,
Minneapolis, MN, USA)). For the differentiation experiments, LUHMES cells were
grown in coated plates with poly-L-lysine (10 mgml 1) followed by ﬁbronectin
(5 mgml 1). Dopaminergic neurons were differentiated in DMEM/F12 medium
with 1% N2-supplement, 1 mgml 1 tetracycline, 100Uml 1 penicillin,
100mgml 1 streptomycin, 0.49mgml 1 dibutyril cyclic AMP (Sigma-Aldrich)
and 2 ng ml 1 glial cell-derived neurotrophic factor52,53. Following 6–7 days of
in vitro differentiation, LUHMES cells expressed the dopamine transporter, the
vesicular monoamine transporter 2, tyrosine hydroxylase and the neuronal form of
b-III tubulin53,65. The immortalized mouse hippocampal HT-22 cells were cultured
in Dulbecco’s modiﬁed Eagle’s medium with the addition of 10% heat-inactivated
fetal calf serum, 100Uml 1 penicillin, 100mgml 1 streptomycin and 2mM
glutamine. Toxicity measurements were performed by administering the sonicated
ﬁbrils at the indicated protein concentrations within the growth medium. After
24 and 48 h of treatment, quantiﬁcation of cell viability was performed via a MTT
(3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) reduction
assay at 0.5mgml 1 for 1 h. The reaction was terminated by removing the MTT
solution and freezing the plate at  20 C for at least 1 h. DMSO solvent was added
to each well for 30min under shaking conditions at 37 C. The absorbance of each
well was determined with a Synergy H1 Multi-Mode reader (Biotek, LA) at 570 nm
with a reference ﬁlter at 630 nm (refs 52,53).
MAS ssNMR spectroscopy. Unless speciﬁed otherwise, MAS ssNMR experi-
ments were performed using a wide-bore Bruker Avance I NMR spectrometer
operating at 1H Larmor frequency of 600MHz (14.1 Tesla) and triple-channel
(HCN) Bruker 3.2mm MAS NMR probes. Isotopically labelled samples were
prepared and packed into 3.2mm MAS rotors using an ultracentrifugal packing
device15,62. CP-based peak assignments were obtained using 2D 13C–13C spectra
employing DARR66 mixing, as well as standard heteronuclear 2D MAS ssNMR
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15462
10 NATURE COMMUNICATIONS | 8:15462 | DOI: 10.1038/ncomms15462 | www.nature.com/naturecommunications
assignment spectra. Dynamics were probed via dipolar-recoupling curves based on
a series of 2D PDSD experiments, with mixing times ranging from 0, 15, 50, 100,
250 to 500ms. 2D peak volumes were integrated using the Gaussian peak ﬁtting
routines of the Sparky NMR software package, and normalized relative to
corresponding diagonal peak volumes at zero mixing. The errors in the measured
peak intensity were estimated based on the noise peak intensities in the spectra.
1H–13C dipolar couplings were probed via DIPSHIFT experiments49 using a
3.2-mm triple-channel HCN MAS probe in a wide-bore 750MHz spectrometer
from Bruker Biospin acquired via NIH S10 grant OD012213-01. The DIPSHIFT
experiments employed a R1817 pulse sequence67,68, at 10 kHz MAS and 277K. We
measured 12 increments constituting a 100 ms rotor period each, up to a maximum
recoupling time of 1.1ms. 1H–13C dipolar recoupling in the DIPSHIFT experiment
was enabled by application of a R1817 pulse sequence on the 1H channel at a 91 kHz
RF power level. The initial 13C signal was generated with CP, using a 1.5ms contact
time. Highly mobile segments of the aggregated exon1 were identiﬁed using scalar-
based spectroscopy employing refocused INEPT 1H–13C transfers combined with
13C–13C transfers using P913 TOBSY69–71. Water-exposure measurements were
performed using ssNMR experiments in which rigid 1H signals were suppressed by
T2 relaxation ﬁltering, after which 1H–1H diffusion facilitated transfer of the
remaining polarization of mobile solvent protons back into the immobilized
protein assemblies13,15. The resulting polarization buildup in the protein residues
was then monitored via 1D 1H–13C CP spectroscopy. 2D 1H–13C spectra were used
to verify the origin of the (mobile) 1H polarization being the aqueous solvent.
T2-ﬁltered 2D 13C–13C DARR spectra were used to verify the identity of dominant
peaks in the T2-ﬁlted 1D spectra.
Experimental details for all spectra are listed in Supplementary Table 2. 1H
decoupling during acquisition and evolution periods was done with two-pulse
phase modulation72, and MAS spinning rates were typically between 8.3 and
13 kHz (see Supplementary Table 2). Spectra were acquired using the Bruker
Topspin software, processed using NMRPipe73. Chemical shifts were assigned and
analysed using the Sparky and CcpNmr Analysis software packages74. Peak
intensities were measured in the Bruker’s Topspin software and CcpNmr Analysis,
with the error in the intensities evaluated based on the noise peaks present in
empty spectral regions. Numerical simulations of the DIPSHIFT experiments were
performed with the SpinEvolution programme15,75. Chemical shift referencing to
4,4-dimethyl-4-silapentane-1-sulfonic acid (for 13C) was performed by indirect
referencing via the 13C signals of adamantane15. Secondary shift calculations were
done using published random coil shifts76.
Data availability. Chemical shifts of the synthetic HNTF peptide ﬁbrils
(httNTQ30P10K2) were reported previously15 and are accessible in the Biological
Magnetic Resonance Data Bank (BMRB) as entry 25146. Assigned shifts of the
mutant htt exon1 ﬁbrils are available in Supplementary Table 3, and in the BMRB
as entry 27045. UniProt entry P42858 has been used in this study. All other data
are available from the corresponding author upon reasonable request.
References
1. Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primers 1, 15005 (2015).
2. Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R. & Finkbeiner, S. Inclusion
body formation reduces levels of mutant huntingtin and the risk of neuronal
death. Nature 431, 805–810 (2004).
3. Sahl, S. J., Weiss, L. E., Duim, W. C., Frydman, J. & Moerner, W. E. Cellular
inclusion bodies of mutant huntingtin exon 1 obscure small ﬁbrillar aggregate
species. Sci. Rep. 2, 895 (2012).
4. Duim, W. C., Jiang, Y., Shen, K., Frydman, J. & Moerner, W. E. Super-
resolution ﬂuorescence of huntingtin reveals growth of globular species into
short ﬁbers and coexistence of distinct aggregates. ACS Chem. Biol. 9,
2767–2778 (2014).
5. Sahl, S. J. et al. Delayed emergence of subdiffraction-sized mutant huntingtin
ﬁbrils following inclusion body formation. Quart. Rev. Biophys. 49, 1–13
(2015).
6. Kodali, R. B., Williams, A. D., Chemuru, S. & Wetzel, R. Ab(1-40) forms ﬁve
distinct amyloid structures whose b-sheet contents and ﬁbril stabilities are
correlated. J. Mol. Biol. 401, 503–517 (2010).
7. Tycko, R. Physical and structural basis for polymorphism in amyloid ﬁbrils.
Protein Sci. 23, 1528–1539 (2014).
8. Nekooki-Machida, Y. et al. Distinct conformations of in vitro and in vivo
amyloids of huntingtin-exon1 show different cytotoxicity. Proc. Natl Acad. Sci.
USA 106, 9679–9684 (2009).
9. Sun, C.-S. et al. Conformational switch of polyglutamine-expanded huntingtin
into benign aggregates leads to neuroprotective effect. Sci. Rep. 5, 14992 (2015).
10. van Ham, T. J. et al. Identiﬁcation of MOAG-4/SERF as a regulator of age-
related proteotoxicity. Cell 142, 601–612 (2010).
11. Falsone, S. F. et al. SERF protein is a direct modiﬁer of amyloid ﬁber assembly.
Cell Rep. 2, 358–371 (2012).
12. Perevozchikova, T., Stanley, C. B., McWilliams-Koeppen, H. P., Rowe, E. L. &
Berthelier, V. Investigating the structural impact of the glutamine repeat in
huntingtin assembly. Biophys. J. 107, 411–421 (2014).
13. Sivanandam, V. N. et al. The aggregation-enhancing huntingtin N-terminus is
helical in amyloid ﬁbrils. J. Am. Chem. Soc. 133, 4558–4566 (2011).
14. Bugg, C. W., Isas, J. M., Fischer, T., Patterson, P. H. & Langen, R. Structural
features and domain organization of huntingtin ﬁbrils. J. Biol. Chem. 287,
31739–31746 (2012).
15. Hoop, C. L. et al. Polyglutamine amyloid core boundaries and ﬂanking domain
dynamics in huntingtin fragment ﬁbrils determined by solid-state nuclear
magnetic resonance. Biochemistry 53, 6653–6666 (2014).
16. Isas, J. M., Langen, R. & Siemer, A. B. Solid-state NMR on the static and
dynamic domains of huntingtin exon-1 ﬁbrils. Biochemistry 54, 3942–3949
(2015).
17. Hoop, C. L. et al. Huntingtin exon 1 ﬁbrils feature an interdigitated b-hairpin-
based polyglutamine core. Proc. Natl Acad. Sci. USA 113, 1546–1551 (2016).
18. Duennwald, M. L., Jagadish, S., Muchowski, P. J. & Lindquist, S. L. Flanking
sequences profoundly alter polyglutamine toxicity in yeast. Proc. Natl Acad. Sci.
USA 103, 11045–11050 (2006).
19. Dehay, B. & Bertolotti, A. Critical role of the proline-rich region in huntingtin
for aggregation and cytotoxicity in yeast. J. Biol. Chem. 281, 35608–35615
(2006).
20. Atwal, R. S. et al. Huntingtin has a membrane association signal that can
modulate huntingtin aggregation, nuclear entry and toxicity. Hum. Mol. Genet.
16, 2600–2615 (2007).
21. Thakur, A. K. et al. Polyglutamine disruption of the huntingtin exon 1 N
terminus triggers a complex aggregation mechanism. Nat. Struct. Mol. Biol. 16,
380–389 (2009).
22. Ellisdon, A. M., Thomas, B. & Bottomley, S. P. The two-stage pathway of
ataxin-3 ﬁbrillogenesis involves a polyglutamine-independent step. J. Biol.
Chem. 281, 16888–16896 (2006).
23. Zboray, L. et al. Preventing the androgen receptor N/C Interaction delays
disease onset in a mouse model of SBMA. Cell Rep. 13, 2312–2323 (2015).
24. Bhattacharyya, A. M. et al. Oligoproline effects on polyglutamine conformation
and aggregation. J. Mol. Biol. 355, 524–535 (2006).
25. Tam, S. et al. The chaperonin TRiC blocks a huntingtin sequence element that
promotes the conformational switch to aggregation. Nat. Struct. Mol. Biol. 16,
1279–1285 (2009).
26. Choudhury, K. R. & Bhattacharyya, N. P. Chaperone protein HYPK interacts
with the ﬁrst 17 amino acid region of huntingtin and modulates mutant
HTT-mediated aggregation and cytotoxicity. Biochem. Biophys. Res. Commun.
456, 66–73 (2015).
27. Monsellier, E., Redeker, V., Ruiz-Arlandis, G., Bousset, L. & Melki, R. Molecular
interaction between the chaperone Hsc70 and the N-terminal ﬂank of
huntingtin exon 1 modulates aggregation. J. Biol. Chem. 290, 2560–2576
(2015).
28. Khoshnan, A., Ko, J. & Patterson, P. H. Effects of intracellular expression of
anti-huntingtin antibodies of various speciﬁcities on mutant huntingtin
aggregation and toxicity. Proc. Natl Acad. Sci. USA 99, 1002–1007 (2002).
29. Southwell, A. L. et al. Intrabodies binding the proline-rich domains of mutant
huntingtin increase its turnover and reduce neurotoxicity. J. Neurosci. 28,
9013–9020 (2008).
30. Legleiter, J. et al. Monoclonal antibodies recognize distinct conformational
epitopes formed by polyglutamine in a mutant huntingtin fragment. J. Biol.
Chem. 284, 21647–21658 (2009).
31. Ehrnhoefer, D. E., Sutton, L. & Hayden, M. R. Small changes, big impact:
posttranslational modiﬁcations and function of huntingtin in Huntington
disease. Neuroscientist 17, 475–492 (2011).
32. Mishra, R. et al. Serine phosphorylation suppresses huntingtin amyloid
accumulation by altering protein aggregation properties. J. Mol. Biol. 424, 1–14
(2012).
33. Wang, C. E. et al. Suppression of neuropil aggregates and neurological
symptoms by an intracellular antibody implicates the cytoplasmic toxicity of
mutant huntingtin. J. Cell Biol. 181, 803–816 (2008).
34. Chow, W. N. V., Luk, H. W., Chan, H. Y. E. & Lau, K.-F. Degradation of
mutant huntingtin via the ubiquitin/proteasome system is modulated by FE65.
Biochem. J. 443, 681–689 (2012).
35. Ko, J., Ou, S. & Patterson, P. H. New anti-huntingtin monoclonal antibodies:
implications for huntingtin conformation and its binding proteins. Brain Res.
Bull. 56, 319–329 (2001).
36. Meier, B. H. & Bo¨ckmann, A. The structure of ﬁbrils from ‘misfolded’ proteins.
Curr. Opin. Struc. Biol. 30, 43–49 (2014).
37. Sahoo, B., Singer, D., Kodali, R., Zuchner, T. & Wetzel, R. Aggregation behavior
of chemically synthesized, full-length huntingtin exon1. Biochemistry 53, 3897–
3907 (2014).
38. Scherzinger, E. et al. Huntingtin-encoded polyglutamine expansions form
amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549–558 (1997).
39. Bennett, M. J. et al. A linear lattice model for polyglutamine in CAG-expansion
diseases. Proc. Natl Acad. Sci. USA 99, 11634–11639 (2002).
40. Poirier, M. A. et al. Huntingtin spheroids and protoﬁbrils as precursors in
polyglutamine ﬁbrilization. J. Biol. Chem. 277, 41032–41037 (2002).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15462 ARTICLE
NATURE COMMUNICATIONS | 8:15462 | DOI: 10.1038/ncomms15462 |www.nature.com/naturecommunications 11
41. Jayaraman, M. et al. Slow amyloid nucleation via a-helix-rich oligomeric
intermediates in short polyglutamine-containing huntingtin fragments. J. Mol.
Biol. 415, 881–899 (2012).
42. Ruggeri, F. S. et al. Nanoscale studies link amyloid maturity with polyglutamine
diseases onset. Sci. Rep. 6, 31155 (2016).
43. Farrell, H. M., Qi, P. X., Wickham, E. D. & Unruh, J. J. Secondary structural
studies of bovine caseins: structure and temperature dependence of b-casein
phosphopeptide (1-25) as analyzed by circular dichroism, FTIR spectroscopy,
and analytical ultracentrifugation. J. Protein Chem. 21, 307–321 (2002).
44. Tooke, L., Duitch, L., Measey, T. J. & Schweitzer-Stenner, R. Kinetics of the self-
aggregation and ﬁlm formation of poly-L-proline at high temperatures explored
by circular dichroism spectroscopy. Biopolymers 93, 451–457 (2010).
45. Schneider, R. et al. Structural characterization of polyglutamine ﬁbrils by solid-
state NMR spectroscopy. J. Mol. Biol. 412, 121–136 (2011).
46. Kar, K. et al. b-hairpin-mediated nucleation of polyglutamine amyloid
formation. J. Mol. Biol. 425, 1183–1197 (2013).
47. Tamiola, K., Acar, B. & Mulder, F. A. A. Sequence-speciﬁc random coil
chemical shifts of intrinsically disordered proteins. J. Am. Chem. Soc. 132,
18000–18003 (2010).
48. Li, J. & Van der Wel, P. C. A. Spinning-rate encoded chemical shift correlations
from rotational resonance solid-state NMR experiments. J. Magn. Reson. 230,
117–124 (2013).
49. Munowitz, M., Grifﬁn, R. G., Bodenhausen, G. & Huang, T. H. Two-
dimensional rotational spin-echo nuclear magnetic resonance in solids:
correlation of chemical shift and dipolar interactions. J. Am. Chem. Soc. 103,
2529–2533 (1981).
50. Scherzinger, E. et al. Self-assembly of polyglutamine-containing huntingtin
fragments into amyloid-like ﬁbrils: implications for Huntington’s disease
pathology. Proc. Natl Acad. Sci. USA 96, 4604–4609 (1999).
51. Lotharius, J. et al. Effect of mutant a-synuclein on dopamine homeostasis in a
new human mesencephalic cell line. J. Biol. Chem. 277, 38884–38894 (2002).
52. Dolga, A. M. et al. Subcellular expression and neuroprotective effects of SK
channels in human dopaminergic neurons. Cell Death Dis. 5, e999 (2014).
53. Ho¨llerhage, M. et al. Triﬂuoperazine rescues human dopaminergic cells from
wild-type a-synuclein-induced toxicity. Neurobiol. Aging 35, 1700–1711 (2014).
54. Larson, M. R. et al. Elongated ﬁbrillar structure of a streptococcal adhesin
assembled by the high-afﬁnity association of a- and PPII-helices. Proc. Natl
Acad. Sci. USA 107, 5983–5988 (2010).
55. Yang, W., Dunlap, J. R., Andrews, R. B. & Wetzel, R. Aggregated polyglutamine
peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 11,
2905–2917 (2002).
56. Pieri, L., Madiona, K., Bousset, L. & Melki, R. Fibrillar a-synuclein and
huntingtin exon 1 assemblies are toxic to the cells. Biophys. J. 102, 2894–2905
(2012).
57. Burke, K. A., Kauffman, K. J., Umbaugh, C. S., Frey, S. L. & Legleiter, J. The
interaction of polyglutamine peptides with lipid membranes is regulated by
ﬂanking sequences associated with huntingtin. J. Biol. Chem. 288, 14993–15005
(2013).
58. De Genst, E. et al. Structure of a single-chain Fv bound to the 17 N-terminal
residues of huntingtin provides insights into pathogenic amyloid formation and
suppression. J. Mol. Biol. 427, 2166–2178 (2015).
59. Steffan, J. S. et al. The Huntington’s disease protein interacts with p53 and
CREB-binding protein and represses transcription. Proc. Natl Acad. Sci. USA
97, 6763–6768 (2000).
60. Yu, A. et al. Protein aggregation can inhibit clathrin-mediated endocytosis by
chaperone competition. Proc. Natl Acad. Sci. USA 111, E1481–E1490 (2014).
61. Marley, J., Lu, M. & Bracken, C. A method for efﬁcient isotopic labeling of
recombinant proteins. J. Biomol. NMR 20, 71–75 (2001).
62. Mandal, A., Boatz, J. C., Wheeler, T. & Van der Wel, P. C. A. On the use of
ultracentrifugal devices for routine sample preparation in biomolecular magic-
angle-spinning NMR. J. Biomol. NMR 67, 165–178 (2017).
63. O’Nuallain, B. et al. Kinetics and thermodynamics of amyloid assembly using a
high-performance liquid chromatography-based sedimentation assay. Methods
Enzymol. 413, 34–74 (2006).
64. Lotharius, J. et al. Progressive degeneration of human mesencephalic neuron-
derived cells triggered by dopamine-dependent oxidative stress is dependent on
the mixed-lineage kinase pathway. J. Neurosci. 25, 6329–6342 (2005).
65. Schildknecht, S. et al. Requirement of a dopaminergic neuronal phenotype for
toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells.
Toxicol. Appl. Pharmacol. 241, 23–35 (2009).
66. Takegoshi, K., Nakamura, S. & Terao, T. 13C-1H dipolar-assisted rotational
resonance in magic-angle spinning NMR. Chem. Phys. Lett. 344, 631–637
(2001).
67. Carravetta, M., Ede´n, M., Zhao, X., Brinkmann, A. & Levitt, M. H. Symmetry
principles for the design of radiofrequency pulse sequences in the nuclear
magnetic resonance of rotating solids. Chem. Phys. Lett. 321, 205–215 (2000).
68. Zhao, X., Ede´n, M. & Levitt, M. H. Recoupling of heteronuclear dipolar
interactions in solid-state NMR using symmetry-based pulse sequences. Chem.
Phys. Lett. 342, 353–361 (2001).
69. Morris, G. A. & Freeman, R. Enhancement of nuclear magnetic resonance
signals by polarization transfer. J. Am. Chem. Soc. 101, 760–762 (1979).
70. Baldus, M. & Meier, B. H. Total correlation spectroscopy in the solid state. The
use of scalar couplings to determine the through-bond connectivity. J. Magn.
Reson. A 121, 65–69 (1996).
71. Andronesi, O. C. et al. Determination of membrane protein structure and
dynamics by magic-angle-spinning solid-state NMR spectroscopy. J. Am.
Chem. Soc. 127, 12965–12974 (2005).
72. Bennett, A. E., Rienstra, C. M., Auger, M., Lakshmi, K. V. & Grifﬁn, R. G.
Heteronuclear decoupling in rotating solids. J. Chem. Phys. 103, 6951–6958
(1995).
73. Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system
based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).
74. Stevens, T. J. et al. A software framework for analysing solid-state MAS NMR
data. J. Biomol. NMR 51, 437–447 (2011).
75. Veshtort, M. & Grifﬁn, R. G. SPINEVOLUTION: a powerful tool for the
simulation of solid and liquid state NMR experiments. J. Magn. Reson. 178,
248–282 (2006).
76. Zhang, H., Neal, S. & Wishart, D. S. RefDB: a database of uniformly referenced
protein chemical shifts. J. Biomol. NMR 25, 173–195 (2003).
Acknowledgements
We thank Michael Delk, Dr Cody Hoop, Dr Kenneth Drombosky and Carmen IJsebaart
for technical assistance and helpful discussions, and Drs James Conway and Alexander
Makhov for use of the electron microscopy facility. We acknowledge funding from the
University of Pittsburgh and National Institutes of Health (NIH grants R01 GM112678
and AG019322 to P.C.A.v.d.W. and R.W., R01 GM099718 to R.W., T32 GM088119 to
J.C.B.), NIH instrument grant S10 OD012213-01 and grant UL1 RR024153 from the
National Center for Research Resources (NCRR). A.M.D. is supported by a Rosalind
Franklin Fellowship co-funded by European Union and University of Groningen. J.C.B.
acknowledges support by the Achievement Rewards for College Scientists (ARCS)
Foundation. Molecular graphics were prepared with UCSF Chimera, developed by
the Resource for Biocomputing, Visualization, and Informatics at the University of
California, San Francisco (supported by NIGMS P41-GM103311).
Author contributions
H.-K.L., P.C.A.v.d.W., J.C.B., Z.H., R.K. and I.E.K. conducted experiments. R.W., R.K.,
A.M.D., M.A.P. and P.C.A.v.d.W. designed experiments; P.C.A.v.d.W. and H.-K.L. wrote
the paper.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Lin, H.-K. et al. Fibril polymorphism affects immobilized
non-amyloid ﬂanking domains of huntingtin exon1 rather than its polyglutamine core.
Nat. Commun. 8, 15462 doi: 10.1038/ncomms15462 (2017).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2017
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15462
12 NATURE COMMUNICATIONS | 8:15462 | DOI: 10.1038/ncomms15462 | www.nature.com/naturecommunications
